Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Juhan

Showing results (41-50 of 244) with videos related to

Pageof 25
Sort By:
Nouvelle Revue Francaise D'Hematologie|June 10, 1978
[Practical aspects of the routine hospital use of the Hemalog D (author's transl)]J Bayle, J J Verdot, I Juhan, et al.
Bailliere'S Clinical Haematology|June 1, 1995
Pathophysiology of fibrinolysisI Juhan-Vague, M C Alessi, P J Declerck
Aviation, Space, and Environmental Medicine|March 10, 1998
Activation of coagulation in decompression illnessA Boussuges, E Succo, I Juhan-Vague, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1984
[Surgery and circulating antiprothrombinase-type anticoagulant in the Soulier-Boffa syndrome]C Martin, C Rud, A Martin, et al.
Journal of Internal Medicine|October 1, 1994
Pathophysiology of fibrinolysisP J Declerck, I Juhan-Vague, J Felez, et al.
Semaine Des Hopitaux. Therapeutique|November 1, 1977
[Therapeutic activity of anti-platelet aggregation agents in arterial diseases]C Delboy, R Jouve, M Escande, et al.
The Journal of Biological Chemistry|February 1, 2000
Tumor necrosis factor alpha up-regulates in an autocrine manner the synthesis of plasminogen activator inhibitor type-1 during induction of monocytic differentiation of human HL-60 leukemia cellsS Lopez, F Peiretti, B Bonardo, et al.
Thrombosis Research|May 15, 1991
Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasmaM C Alessi, I Juhan-Vague, P J Declerck, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Fibrinogen, obesity and insulin resistanceI Juhan-Vague, P Morange, J F Renucci, et al.
European Journal of Nuclear Medicine|January 1, 1983
Functional and ultrastructural alterations of autologous platelets labeled with 111In-oxineP Bernard, M Bazan, C Foa, et al.
Pageof 25

Showing results (41-50 of 244) with videos related to

Sort By:
Pageof 25
Nouvelle Revue Francaise D'Hematologie|June 10, 1978
[Practical aspects of the routine hospital use of the Hemalog D (author's transl)]J Bayle, J J Verdot, I Juhan, et al.
Bailliere'S Clinical Haematology|June 1, 1995
Pathophysiology of fibrinolysisI Juhan-Vague, M C Alessi, P J Declerck
Aviation, Space, and Environmental Medicine|March 10, 1998
Activation of coagulation in decompression illnessA Boussuges, E Succo, I Juhan-Vague, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1984
[Surgery and circulating antiprothrombinase-type anticoagulant in the Soulier-Boffa syndrome]C Martin, C Rud, A Martin, et al.
Journal of Internal Medicine|October 1, 1994
Pathophysiology of fibrinolysisP J Declerck, I Juhan-Vague, J Felez, et al.
Semaine Des Hopitaux. Therapeutique|November 1, 1977
[Therapeutic activity of anti-platelet aggregation agents in arterial diseases]C Delboy, R Jouve, M Escande, et al.
The Journal of Biological Chemistry|February 1, 2000
Tumor necrosis factor alpha up-regulates in an autocrine manner the synthesis of plasminogen activator inhibitor type-1 during induction of monocytic differentiation of human HL-60 leukemia cellsS Lopez, F Peiretti, B Bonardo, et al.
Thrombosis Research|May 15, 1991
Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasmaM C Alessi, I Juhan-Vague, P J Declerck, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Fibrinogen, obesity and insulin resistanceI Juhan-Vague, P Morange, J F Renucci, et al.
European Journal of Nuclear Medicine|January 1, 1983
Functional and ultrastructural alterations of autologous platelets labeled with 111In-oxineP Bernard, M Bazan, C Foa, et al.
Pageof 25